—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Sandoz Group AG (SDZ.SW) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for SDZ.SW, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 61/100 · S&P 500 fund at 75, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-10-06
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 98th percentile of the window, +5.7% over 20 sessions. Factor regime → 2026-10-06
  • Sovereign pressure Index 0.74 · up 0.17 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-10-06

Company snapshot — Sandoz Group AG

SDZ.SW in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Sandoz develops, makes and sells generic drugs and biosimilars, medicines that copy an original biologic once its patent expires. Its products span areas such as cardiovascular, oncology, infectious disease and immunology, alongside active ingredients and finished dosage forms sold to other manufacturers. It has a partnership with Shanghai Henlius Biotech aimed at widening access to its biosimilar medicines. The company is based in Basel, Switzerland.
Where it sits in the stack
Sandoz carries no seat in our index; it sits in our universe's Healthcare sleeve, within the generic and biosimilar drug manufacturing group rather than any AI build-out layer.
Who it is priced against
The diary has no assigned peer group for Sandoz; the comparison the market draws is with other biosimilar and generics makers such as Teva.
Why Closelooknet tracks it
Sandoz holds no Closelooknet index seat and carries no score yet, so no module can be called stronger or weaker; the diary has not quoted it in an edition.
What the diary watches
Whether the Henlius collaboration expands the biosimilar portfolio enough to offset pricing pressure in the older generics business.

Sandoz Group AG (SDZ.SW) trades on the SW exchange in Switzerland.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Dividends and capital return trailing yield 1.15%, annual · last 0.80 CHF on 2026-04-13

Dividends and capital return

What SDZ.SW pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 0.80 CHF per share · a 1.15% yield on the 2026-10-06 close 1 distribution, paid once a year 2026-10-06
  • Change on the year +33.3% against the prior twelve months prior twelve months 0.60 CHF per share
  • Last distribution 0.80 CHF per share as the price series records it, within days of the ex-date 2026-04-13
  • By calendar year 2025: 0.60 CHF (partial) · 2026: 0.80 CHF to date first distribution recorded in the three-year window: 2025-04-17

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-10-07

Quick answers

What is Sandoz Group AG (SDZ.SW)?

Sandoz Group AG trades as SDZ.SW on the SW exchange (Switzerland) in the Closelooknet research universe, as of the registry build of 2026-10-07.

Is SDZ.SW in a Closelooknet index?

Not currently — Sandoz Group AG is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-10-07.

Where does SDZ.SW trade against its moving averages?

Pullback inside an uptrend stack: Trades -0.1% vs the 50-day and +6.5% vs the 200-day average, 8.1% below the 52-week high and +54.2% off the 52-week low. Computed from daily closes. As of 2026-10-06 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

What does Sandoz Group AG do?

Sandoz develops, makes and sells generic drugs and biosimilars, medicines that copy an original biologic once its patent expires. Its products span areas such as cardiovascular, oncology, infectious disease and immunology, alongside active ingredients and finished dosage forms sold to other manufacturers. It has a partnership with Shanghai Henlius Biotech aimed at widening access to its biosimilar medicines. The diary has no assigned peer group for Sandoz; the comparison the market draws is with other biosimilar and generics makers such as Teva.

Where does Sandoz Group AG sit in the AI build-out?

Sandoz carries no seat in our index; it sits in our universe's Healthcare sleeve, within the generic and biosimilar drug manufacturing group rather than any AI build-out layer. Sandoz holds no Closelooknet index seat and carries no score yet, so no module can be called stronger or weaker; the diary has not quoted it in an edition.

Does Sandoz Group AG pay a dividend?

Sandoz Group AG has paid 0.80 CHF per share over the last twelve months, paid once a year, a trailing yield of 1.15% on the 2026-10-06 close; the last distribution recorded in the price series was 0.80 CHF on 2026-04-13. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for SDZ.SW, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.